Objective. To determine the effectiveness and risks of fluoroscopically guided lumbar interlaminar epidural steroid injections.
Interventions. Three reviewers with formal training in evidence-based medicine searched the literature on fluoroscopically guided lumbar interlaminar epidural steroid injections. A larger team consisting of five reviewers independently assessed the methodology of studies found and appraised the quality of the evidence presented.
Outcome Measures. The primary outcome assessed was pain relief. Other outcomes such as functional improvement, reduction in surgery rate, decreased use of opioids/medications, and complications were noted, if reported. The evidence on each outcome was appraised in accordance with the Grades of Recommendation, Assessment, Development and Evaluation (GRADE) system of evaluating evidence.
Results. The search yielded 71 primary publications addressing fluoroscopically guided lumbar interlaminar epidural steroid injections. There were no explanatory studies and all pragmatic studies identified were of low quality, yielding evidence comparable to observational studies.
Conclusions. The body of evidence regarding effectiveness of fluoroscopically guided interlaminar epidural steroid injection is of low quality according to GRADE. Studies suggest a lack of effectiveness
Introduction
The use of epidural injections for the treatment of spine pathology was described by Evans in 1930 [1] . Traditionally, this procedure was performed using an anatomic landmark-guided, or "blind" technique without fluoroscopic guidance, as described by Barry and Kendal [2] . However, the lack of image guidance introduces the potential for inaccurate needle placement. Inaccuracy may result in the injectate failing to reach the right level or side, or possibly even worse, the injectate going to undesired locations such as a blood vessel or the subarachnoid space. White et al. found that inaccurate needle placement occurred in 25% to 30% of injections even in the hands of experienced physicians [3, 4] . Given that the goal of a spine injection is to deliver an aliquot of medicine to a specific target, the efficacy and safety of this procedure may be contingent upon the accurate delivery of the proposed injectate. The potential complications of intrathecal steroid injections, such as adhesive arachnoiditis, have been well described [5, 6] . In addition, despite negative needle aspiration, a significant number of injections following blind needle placement have been proven to be intravascular [4, 7] .
Once the high rate of inaccurate needle placement associated with blind techniques was elucidated, investigators began exploring use of fluoroscopically guided injections and epidurography to document accurate needle placement before injection of therapeutic substances [8] [9] [10] [11] [12] [13] . The first fluoroscopically guided epidural injection was reported in the early 1980s [4] . Today, interlaminar epidural steroid injections are one of the most commonly performed interventions in managing spine pain in the United States [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] . The purpose of this review was to identify all publications on fluoroscopically guided lumbar interlaminar epidural steroid injections (L-ILESI) and to assess the data with regard to effectiveness based on the underlying pathology, as well as the risks of the procedure so that appropriate use criteria can be developed. Most reviews to date have indiscriminately combined fluoroscopically guided and non-image-guided L-ILESI. Therefore, the purpose of this review was to focus solely on the outcomes and complications reported from fluoroscopically guided L-ILESI. Additionally this review attempted to further stratify outcomes based on underlying pathology. The information from this review can be compared to the effectiveness and efficacy data outlined in reviews of other procedures to guide appropriate evidence-based medical decision-making [24] .
Methods
Three investigators, who all have formal training in evidence-based medicine and are members of the Standards Division of the Spine Intervention Society, searched the scientific literature independently for publications on the effectiveness and for any unwanted effects of fluoroscopically guided L-ILESI. The literature search was conducted in PubMed using the keywords lumbar, epidural, steroid, injection, radicular pain, radiculopathy, radiculitis, stenosis, and back pain. The searches encompassed all scientific papers published until March 2016. Studies were excluded for the following reasons: non-English language papers, nonhuman studies, conference abstracts, case reports (unless they were reports of complications), less than 2 weeks follow-up, and technical considerations as outlined in Table 1 . When suitable papers were retrieved, the references of each were perused for relevant citations that had not been identified by the database searches.
Similar to previous systematic reviews done by the Standards Division, studies were sorted based upon their contents, methodology, and study type [24] [25] [26] [27] . The papers retrieved by the searches were sorted by each of the investigators into two groups: primary publications (reports of studies that produced original data) and secondary publications (those not producing original data, such as literature reviews, editorials, and letters). The primary publications on the effectiveness of fluoroscopically guided L-ILESI were then classified by each of the investigators into three categories termed: observational studies, pragmatic studies, and explanatory studies. Observational studies were defined as those that simply described the outcomes observed after the use of an intervention; note was taken of whether the observational study design was prospective or retrospective, and whether patients were consecutively enrolled. Pragmatic studies were defined as those in which the outcomes of one intervention were compared with those of another intervention expected to have a therapeutic effect. Explanatory studies were defined as those in which the outcomes of an intervention were compared with those of an intervention not expected to have a therapeutic effect. Of special notemany researchers have designed their randomized controlled trials (RCTs) using local anesthetic as a placebo control. However, because there are some data to suggest that local anesthetic may have some therapeutic effect, those studies that compared fluoroscopically guided L-ILESI to local anesthetic were considered pragmatic studies in this review [28, 29] .
The primary papers on effectiveness of fluoroscopically guided L-ILESI were then appraised by each of the investigators independently, using an instrument developed by the Society's Standards Division to facilitate reliable assessment of studies of therapeutic effectiveness. The instrument assesses study design and objective; the study population; the intervention under study and any other intervention used for comparison; the outcomes considered and the instruments used to evaluate them; the results reported and the times they were observed after the intervention; any apparent methodological limitations, including non-blinded observers; losses to follow-up; non-consecutive patients; etc. It also records the reviewer's assessment of the paper and the data it reported, with specific attention to any apparent biases or inconsistencies, the precision of estimates of effect (including confidence intervals of data), and any confounding factors. Each reviewer then made a general comment led by the question: "Irrespective of what the authors may or may not have written, does the study provide valid data on the effectiveness of fluoroscopically guided L-ILESI, and if so, how compelling are those data?" When the investigators had each completed their independent appraisals of the effectiveness papers, they shared the results of their assessments and discussed any differences of opinion on particular papers until they reached consensus on the value of each paper's contribution to the published evidence of the effectiveness of fluoroscopically guided L-ILESI. The assessments were then appraised by other members of the Society's Standards Division (all also trained in evidence-based medicine).
The resultant body of evidence was analyzed to determine whether it provided evidence of effectiveness using the Grades of Recommendation, Assessment, Development and Evaluation (GRADE) system of evaluating evidence to determine the quality of the evidence. In essence, the GRADE system asks reviewers to transparently evaluate the body of evidence with consideration not only to study design, but attributes that would strengthen or weaken confidence in the estimate of effect. GRADE provides for an initial rating of quality based upon the best available evidence that comprises the evidence base, then further requires consideration of weaknesses (e.g., risk of bias, indirectness) that merit downgrading and strengths (e.g., magnitude of effect, dose response gradient) that would justify upgrading the rating of the quality of the body of evidence.
Since lumbar radicular pain and low back pain are merely symptoms of a variety of conditions that clearly have different natural histories and possibly different responses to interventional therapy, when possible the data were grouped by the underlying spinal pathology with the focus being intervertebral disc displacement and lumbar spinal stenosis.
Using the same search strategies, the investigators also reviewed studies and reports on the risks of fluoroscopically guided L-ILESI. The information provided in the reports of complications was collated and the resultant body of evidence was evaluated using the GRADE system of appraisal to determine the quality of the evidence for the risks of fluoroscopically guided L-ILESI. The published data on the effectiveness and risks of this procedure were both taken into account, and overall conclusions were drawn in accordance with the GRADE system.
Results
A literature search yielded 71 articles on fluoroscopically guided L-ILESI for treatment of lower extremity and/or low back pain due to a variety of etiologies. These articles were assigned into the categories noted in Figure 1 . Of the 71 articles, 41 met the established inclusion criteria. There were 27 papers addressing the effectiveness of fluoroscopically guided L-ILESI and 14 publications that discussed aspects of the safety of the procedure and its associated risks.
Effectiveness

Radicular Pain Due to Lumbar Disc Herniation
Observational Studies. Three small observational studies provide conflicting evidence regarding the effectiveness of fluoroscopically guided L-ILESI in the treatment of radicular pain due to lumbar disc herniation. One study by Ghai et al. was conducted as an RCT, but both treatments studied were fluoroscopically guided L-ILESI, and differed only with respect to placing the needle midline or parasagittal. Therefore, for present purposes, each arm was considered as an observational study [30] .
The study by Furman et al. [31] [32] , which is less than half of the minimal clinically important change for lumbar radicular pain in pain for patients with sciatica [33] .
Pragmatic Studies.
Twelve pragmatic studies investigating efficacy of fluoroscopically guided L-ILESI in patients with radicular pain were published between 2007 and 2016. Seven studies compared the effectiveness of the interlaminar approach with either the transforaminal route [34] [35] [36] [37] [38] or with both transforaminal and caudal routes [39, 40] . Rados et al. [37, 38] and Ghai et al. [34] reported improvement in all the outcomes in both groups without a statistically significant difference between them. However, the other studies all demonstrated better effectiveness of the transforaminal route [35, 36, 39, 40] .
One RCT compared the effectiveness of L-ILESI with two different steroid preparations (dexamethasone and methylprednisone) and failed to demonstrate a significant difference in outcomes between the two [41] . Another study found similar outcomes of aggregated (both interlaminar and transforaminal) lumbar epidural steroid injections done based on clinical picture compared with one performed based on clinical picture and magnetic resonance imaging (MRI) results [42] . Since all of the above-mentioned pragmatic RCTs failed to demonstrate superiority of L-ILESI over other treatments, the body of evidence provided by these studies in addressing the effectiveness of L-ILESI in treating radicular pain is of low quality, and therefore, comparable to observational studies.
One double-blind pragmatic RCT compared the effectiveness of L-ILESI of local anesthetic with and without steroid in patients with lumbar radicular pain caused by disc herniation and found "potential superiority of steroids" in improving the outcomes at 1-year follow-up [43] . The inclusion/exclusion criteria in this study were well defined. One hundred and twenty patients were randomly assigned to two groups. The subjects were randomized to L-ILESI with 6 ml of 0.5% lidocaine or an L-ILESI of 5 ml of 0.5% lidocaine and 1 ml of betamethasone. The interventional technique was adequately described and the outcome measures included numeric rating scale (NRS), Oswestry Disability Index (ODI), employment status, and reduction in opioid intake. The primary outcome was "significant" improvement defined as 50% or more reduction in pain scores and ODI at 3-month, 6-month, and 12-month follow-ups. Most patients had several (up to five) procedures during the study. Loss to follow-up was 10%. Successful outcomes for those receiving lidocaine only were reported in: 72% [95% (CI): 61-83%] at 3 months, 63% [95% (CI): 51-75%] at 6 months, and 67% (95% CI: 55-79%) at 12 months. For those receiving lidocaine and betamethasone, successful outcomes were reported in: 82% (95% CI: 72-92%) at 3 months, 85% (95% CI: 76-94%) at 6 months, and 85% (95% CI: 76-94%) at 12 months. With overlapping confidence intervals at 3 months and 12 months, the success rates are not statistically significantly different. The NRS scores decreased more in those receiving a corticosteroid compared to the local anesthetic only group (P ¼ 0.02), and so did the ODI scores (P ¼ 0.026). Overall, this was a well-designed study with proper randomization and allocation concealment. Intent-to-treat analysis was applied and co-interventions were controlled for. The outcome measures reached minimal clinically important change as demonstrated by categorical data. One potential flaw of this study is that numerous L-ILESI were performed on the same patients and, therefore, the effectiveness of a single procedure remains unknown. The counterargument to that is that many patients, outside of the strictly controlled research settings, often receive more than one L-ILESI a year. Thus, this study may be considered as better representing "the real world". Another drawback is the choice of a steroid used for epidural injection. Betamethasone is rarely used by pain practitioners because of its high cost and inferior effectiveness as compared with the other steroids commonly used for this intervention [44] . The more egregious flaw, however, concerns the most important categorical outcome of the trial -the success rate of the treatment. Surprisingly, it is not even reported in the article's abstract but rather mentioned in the results section only. While the 6-month data demonstrate decreased pain and functional improvement with inclusion of steroid, the overlapping 95% confidence intervals at 3 and 12 months suggest the two treatments are equivalent at those timeframes, failing to support the authors' conclusion of "potential superiority of steroids compared with local anesthetic alone at 1-year follow-up." However, it is difficult to interpret the data accurately because the authors performed several ESIs on each patient in a rather haphazard fashion. It is possible that before the 6-month follow-up data collection, a greater proportion of patients received the injection more recently compared with the 3-and the 12-month data collection periods. If so, that may explain the inconsistency of the results.
Two pragmatic studies assessed the effectiveness of a parasagittal lumbar interlaminar approach. In 2015, Ghai et al. performed a pragmatic RCT assessing the effectiveness of fluoroscopically guided parasagittal interlaminar injections of local anesthetic with and without steroid for patients with chronic low back pain and uniradicular pain [45] . At 3 months, 86% of patients in the steroid group reported greater than 50% improvement (90% CI: 73-93%) as compared to 50% in the local anesthetic group (90%: CI 36-64%). Similar results were obtained at 6, 9, and 12 months. This study seems to provide some evidence of greater effectiveness of parasagittal interlaminar epidural steroid injections compared to epidural injections of a local anesthetic. An important confounding factor is the unknown timing of additional injections in relation to the fixed in time follow-up appointments. If some patients received these additional injections close to the followup dates they might show much better results skewing the data. Also, the authors chose the unusually broad exclusion criteria, not only excluding patients with large disc herniation but also those with any signs of radiculopathy, thereby rendering the criteria much different from those used in the vast majority of other studies. Hashemi et al. conducted a pragmatic RCT comparing transforaminal and parasagittal injections in patients with radicular pain and found that the success rate, defined as NRS < 3, was not different between the groups [46] . The authors concluded that both techniques were equally effective with 77.3% of parasagittal LESI patients (95% CI: 67-90.5%) and 74.2% of transforaminal LESI patients (95% CI: 62.4-89.4%) gaining success at 2 to 4 weeks. However, a short follow-up in this study tempers the optimism inspired by these positive results.
Radicular Pain Due to Lumbar Spinal Stenosis
Four observational studies have addressed the effectiveness of fluoroscopically guided L-ILESI for spinal stenosis. Three suggested that short-term improvement could occur, but provide no data on success rates [47] [48] [49] . The fourth study found no improvements [50] .
In 2014, a pragmatic multicenter, double-blind RCT was published comparing the effectiveness of epidural injections (both transforaminal and interlaminar) containing lidocaine with and without steroids in patients with spinal stenosis [51] . The primary outcome measures were Roland-Morris Disability Questionnaire (RMDQ) and NRS for leg pain at 3 and 6 weeks. The inclusion/exclusion criteria in this study were well-defined and focused on central spinal stenosis. Patients were randomized to two groups: lidocaine 0.25-1%, 1-3mls; and lidocaine 0.25-1%, 1-3mls and 1-3mls of steroid (60-120 mg of triamcinolone or methylprednisonole, 6-12 mg of betamethasone, 8-10 mg dexamethasone). It was a doubleblinded study carried out by 26 different physicians. Of the 200 patients in the lidocaine only group, 139 had an interlaminar injection, while 61 received a transforaminal injection, all under fluoroscopic guidance. Of the 200 patients in the lidocaine and steroid group, 143 had an interlaminar injection and 57 had a transforaminal injection, under fluoroscopic guidance. Outcomes were assessed at 3 and 6 weeks. The data were presented as the mean of continuous data for each group. Patients who received interlaminar injections assigned to glucocorticoids plus lidocaine compared to those assigned to lidocaine alone reported better physical function on the RMDQ and less leg pain at 3 weeks which were statistically significant, but there were no significant differences between the two treatment groups at 6 weeks. The authors concluded that in the treatment of lumbar spinal stenosis, epidural injection of glucocorticoids plus lidocaine offered minimal or no short-term benefit as compared with epidural injection of lidocaine alone. To facilitate recruitment, the study allowed blinded cross over between treatment arms. Of the 200 subjects that initially received steroid and lidocaine, only 60 or 30% (95% CI 24-37%) crossed over; while 90 or 45%(95% CI 38-51%) of the 200 patients treated initially with lidocaine crossed over. It is interesting that there was a statistically significant difference, with more people that only received lidocaine crossing over than those that initially received steroids [52] .
This is considered an important study as it mimics clinical practice; however, there are a number of limitations. The inclusion criteria were loose and many patients' pain and disability may not be the result of stenosis. In addition, the variability in both volume (1-6 mls) lidocaine dose and steroid dose and type injected could impact the results and this was not accounted for. No images were included to assess placement or contrast flow patterns. There were multiple physicians involved in performing the procedures. They did not control for or even mention confounding factors such as medication use. Categorical data were not provided, nor were data on some of the more salient outcome measures such as the Swiss Spinal Stenosis Questionnaire. They did not present baseline and post-injection data for each group; rather they provided results only on the between-group differences without adequate subgroup analysis. Therefore, in academic terms, this study might be criticized for not applying uniform, rigorous selection criteria, for not standardizing dosages, for using multiple treating physicians, and for not controlling for cointerventions. However, the practices of the physicians and the patients enrolled reflect what happens in actual clinical practice. So despite the significant limitations mentioned above, this study may be representative of normal clinical practice and appears to support the conclusion that steroids are only minimally more effective than local anesthetic at 3 weeks.
In 2015, another double blind pragmatic RCT was published that compared the effectiveness of an L-ILESI with local anesthetic only to an L-ILESI with local anesthetic and corticosteroid in patients with lumbar radicular pain caused by central spinal stenosis [53] . This study was completed by the same authors as the previously detailed manuscript comparing L-ILESI of lidocaine only to lidocaine and corticosteroid for disc herniations [43] . Outcomes were assessed at baseline and at 3, 6, 12, 18, and 24 months post-treatment, and included NRS and ODI, with success defined as a decrease in either measure by 50%. The authors found that 72% (95% CI: 61-83%) of patients receiving lidocaine and corticosteroid and 73% (95% CI: 62-85%) of patients that received lidocaine only had significant pain relief at 24 months. ODI scores decreased by 75% in both groups at 24 months. The authors concluded that epidural injection of glucocorticoids plus lidocaine offers no benefit as compared with epidural injection of lidocaine alone. However, this study had the same methodological flaws outlined above that permeated the authors' other study [43] .
Staats et al. performed a pragmatic RCT comparing the effectiveness of fluoroscopically guided L-ILESI to the MILD (minimally invasive lumbar decompression) procedure in the treatment of spinal stenosis and reported greater improvements in patients' symptoms with the latter treatment [54] . However, the lack of blinding and some other notable shortcomings of this study cast doubts on the relevancy and validity of the presented data. Because the first follow-up in the study was not conducted until after 6 months after each procedure the shorter lasting positive effects of epidural steroid injections might not be registered.
Radicular Pain of Unclear Etiology
Two studies were identified that evaluated the effectiveness of fluoroscopically guided L-ILESI in patients with radicular pain of uncertain etiology. A prospective observational study by Burn et al. evaluated 6-month outcomes following L-ILESI or caudal epidural steroid injections in 56 patients with radicular pain resulting from uncertain etiology [55] . Of the 29 patients in the L-ILESI subgroup that received 20 ml of 0.75% lidocaine mixed with 20 mg hydrocortisone and 80 mg of methylprednisolone, 18 [62% [(95% CI: 44-80%)] reported relief of pain from radicular symptoms at 6 months; however, the authors do not quantify the degree or percentage of pain relief. No conclusion can be drawn from this study as the technique is not consistent with standards: large volume was injected at the L3-4 level, two different steroids were used, and some cases were performed using a catheter.
Annaswamy et al. evaluated whether an abnormal needle electromyography (NEE) would predict positive outcomes after L-ILESI [56] . Patients with abnormal NEE experienced better outcomes; however, both groups failed to achieve a minimal clinically important change, reporting less than 2-point reduction on the VAS.
Back and/or Leg Pain Due to Unclear or Multiple Etiologies
A 2003 study by Noe and Haynsworth compared the effects of fluoroscopically guided L-ILESI with methlyprednisone to betamethasone in patients with low back pain with or without radiculopathy [57] . The 23% loss to follow-up, absence of categorical data, and results reported only at 4 weeks, limits the obtainable insight into the effectiveness of L-ILESI in treating patients with back and/or leg pain of uncertain etiology.
A pragmatic RCT compared the effectiveness of interlaminar with bilateral transforaminal epidural steroid injections in the treatment of spine pain and pathology in patients with lumbosacral disc herniation or spinal stenosis [58] . Of the patients with stenosis treated with an interlaminar injection, 36% (95% CI: 21-50%), compared with 61% (95% CI: 49-74%) for the transforaminal group, experienced a successful outcome at 2 months, defined as at least a 2-point reduction on the NRS pain scale. For patients with disc herniation, no differences between groups were noted at up to 4 months.
In 2012, Manchikanti et al. performed a pragmatic RCT of 120 patients to assess the effectiveness of fluoroscopically guided lumbar interlaminar injection of local anesthetic with and without steroid in managing chronic low back pain of discogenic origin [59] . Discogenic pain was diagnosed by absence of relief from medial branch blocks or SI joint injection. This is clearly not a validated means of diagnosing "discogenic pain," which resulted in the study being categorized for purposes of this review as providing evidence relative to use of L-ILESI in treating back and/or leg pain of uncertain etiology. In this study, the subjects received either local anesthetic only or a mixture of local anesthetics. Similar to this research groups other studies comparing interlaminar anesthetic to interlaminar anesthetic and corticosteroid in spinal stenosis [49] and disc herniations [42] , all subjects improved and no differences were found between the groups in NRS and ODI at 3, 6, and 12-months post enrollment. Unfortunately this paper also contained significant flaws, such as allowing multiple injections for which timing and exact numbers were not adequately controlled, thus limiting the ability to draw real insights and conclusions.
Complications and Adverse Effects
In order to accurately report on complications due to fluoroscopically guided L-ILESI, it is imperative to differentiate true reported complications from minor adverse effects. Additionally it is useful to stratify the adverse effects into: generic effects expected of any invasive procedure, those attributable to the agents injected, and technical mishaps peculiar to epidural placement of needles.
True complications following fluoroscopically guided L-ILESI appears to be limited to mostly case reports (see Table 2 ). In fact a large cohort of over 1,500 consecutive injections revealed no major complications [60] .
Further review of the case reports on complications due to fluoroscopically guided L-ILESI revealed several potentially clinically significant complications including: chemical meningitis following inadvertent dural puncture/intrathecal steroid administration [61] , "transient" blindness with retinal hemorrhages on ophthalmologic examination but with permanent vision changes [62] , paraplegia [63] , soft tissue abscess associated with osteomyelitis [64] , epidural abscess [65] , and epidural hematoma [66, 67] .
The case report by Young et al. describes a patient that developed transient blindness (20/400 vision bilaterally) with eventual vision improvement to 20/40 (B/L), but who also developed diabetes mellitus, previously not diagnosed, with requirement of insulin on a temporary basis [62] . In regards to the transient blindness, there have been nine previously reported cases with retinal hemorrhages seen on fundoscopic examination [62] . Permanent paraplegia following L1-2 ILESI in a patient with prior L3-4 posterior fusion has been described by Lenoir et al. due to unknown mechanism, possibly through an embolic event due to a variation in the arterial blood supply to the spinal cord, as seen in the transforaminal route [63] .
Hooten et al. reported on a patient with L5-S1 discitis with Coagulase negative Staphylococcus post L5-S1 ILEI, requiring complete L5 laminectomy, L5-S1 discectomy, and bilateral medial facetectomies in a 64-yearold with a history of recurrent pulmonary infections [68] . The patient was treated with 6 weeks of IV antibiotics. At 3 months follow-up, the patient reported no lumbosacral spine, radicular lower limb pain, and the patient's weakness in the lower limbs had improved.
Simopoulos et al. described a soft tissue abscess with osteomyelitis with methicillin-resistant Staphylococcus Aureus (MRSA) in an immunocompromised (diabetes mellitus) patient following a second injection in a series of L-ILESIs for radicular pain due to lumbar stenosis [64] . This patient had proper aseptic techniques, but was immunocompromised, and therefore at higher risk of developing an abscess/osteomyelitis. The authors recommended using Chlorhexidine-based solutions when possible, as they may be associated with better skin disinfection for pain procedures in patients with risk factors for immunosuppression. Linn et al. described an 81-year-old patient who had a history of AFib with previous neuraxial procedures while Coumadin was held per guidelines [69] , who developed non-reversible, permanent aphasia and left hemiparesis due to a right middle cerebral artery cerebrovascular accident [70] . While not directly due to the procedure, this complication may have been caused by holding of the anticoagulants in preparation for the procedure. Epidural hematoma has been described in a patient bridged with enoxaparin [66] and in a patient with undiagnosed Idiopathic Thrombocytopenic Purpura [67] .
Minor adverse events that are transient in nature and not true complications have also been reported following fluoroscopically guided L-ILESIs. These include: inadvertent disc entry without discitis, flushing, increased or new pain, bleeding, post-injection headache, chest pain, itching/pruritis, weakness, leg cramps, abnormal limb movement, swelling, heart palpitations, diarrhea, night sweats/fevers/chills, muscle spasm, pressure, other back pain, stiffness, numbness, or transient bowel incontinence [60, 61, 71, 72] . Some of these adverse events are due to the mere act of placing a needle and clearly not unique to fluoroscopically guided L-ILESIs. This would include adverse events such as increased pain and vasovagal syncope, both of which have been reported on from large cohorts. Increased pain is one of the most commonly reported adverse events, but in large studies has been found to occur less than 2% of the time [60] . Vasovagal syncope is another well-studied adverse event due to needle placement. One study of 279 consecutive subjects reported 20 [0.7% [(95% CI: 0.5-0.1%)] with transient vasovagal syncope [73] , while another larger multi-site study of 1,412 consecutive subjects noted only 3 [0.02% [(95% CI: 0.007-0.06%)] episodes of transient vasovagal syncope [60] .
There are also reported effects that are felt to be secondary to the injection of a corticosteroid or other medications. These would therefore not be unique to LILESIs and would include: sleeplessness, non-positional headaches, increased blood glucose, facial flushing, adrenal suppression, and allergic reactions [74] [75] [76] [77] [78] . Central steroid effects, defined as sleeplessness, flushing and a non-positional headache, have been shown to occur in 2.6% (95% CI: 1.9-3.4%) of patients [60] .
Lastly adverse events can also occur due to technical mishaps. In a large cohort, dural punctures have been reported at low rates of 0.2% (95% CI: 0.9-0.6%) [60] . Unintended injection into a disc [68, 79] has also been reported in case reports. While dural puncture has been reported from procedures done according to the Society's standards, intradiscal injections should not occur in correctly performed image-guided procedures.
Discussion
A systematic review completed by members of the Society's Standards Division earlier this year addressed the effectiveness and risks of blind L-ILESI (in press). The authors of that review determined that there is no role for the routine use of blind L-ILESI in the treatment of spine pathology resulting in pain. They suggested that the evidence should be reviewed to determine whether fluoroscopic guidance results in improved outcomes that would support the use of the interlaminar approach in treating radicular pain, neurogenic claudication, and axial low back pain. Use of fluoroscopy offers several advantages when performing L-ILESI, including: verification of the correct level and side; confirmation, with use of contrast medium, that the injection is accurately placed in the epidural space; and avoidance of intravascular injection. Despite these demonstrated advantages, there have been several systematic reviews undertaken in the past with conflicting results regarding the effectiveness of fluoroscopically guided L-ILESI.
Previous systematic reviews have used traditional methods to assess the evidence, which rely on RCTs but abjure observational studies. These reviews come to very different conclusions regarding the effectiveness of fluoroscopically guided L-ILESI [80] [81] [82] [83] [84] , but almost all agree that epidural steroid injections provide short-term improvement of radicular pain associated with disc herniation or spinal stenosis. Unlike these previous reviews, the present review employed the GRADE system of appraisal Figure 1 Categorization of potentially relevant articles generated by the literature search.
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to determine the quality of the evidence regarding the effectiveness of fluoroscopically guided L-ILESI.
Additionally this review focused on separating the results by the likely underlying pathology, as varying pathologies may have different responses to treatment and they clearly have different natural histories. The disease specific natural history is imperative to consider when discussing the duration of relief. For instance, radicular pain due to a disc herniation typically has a favorable natural history for resolution of pain. This is in stark contrast to neurogenic claudication due to spinal stenosis, which while not generally progressive, does not tend to spontaneously resolve. For those conditions with a favorable natural history, a short duration of relief from a given treatment may be reasonable. The decision to implement the treatment would take the risks and benefits into consideration, in addition to the symptom severity, impact on function, and even total costs including costs of alternative treatments and lost productivity due to inability to work. In the case of radiculopathy due to a disc herniation a short duration of relief that results in less utilization of other health care and a quick return to work may be appropriate. However, a similar short-term effect may be insufficient for a chronic condition such a spinal stenosis.
When assessing the level of evidence in accordance with GRADE and stratifying by underlying pathology, trends do emerge. For all conditions, the quality of evidence is low in accordance with GRADE. There were no reasons to justify upgrading the evidence for any pathology. To qualify for such an "upgrade" in GRADE methodologically, the evidence provided by observational studies must demonstrate a large magnitude of effect or the presence of a dose-response gradient. Neither of these conditions apply. In addition, many of the studies had several flaws as discussed in detail in the results section.
This low rating in accordance with GRADE is due to the lack of explanatory RCTs for fluoroscopically guided L-ILESI. The literature search yielded twelve pragmatic studies addressing the use of fluoroscopically guided L-ILESI for radicular pain due to herniated disc, and five for spinal stenosis. All of these studies failed to show superiority of L-ILESI to the comparative treatment, with the exception of two studies: one found L-ILESI superior only at 6 months for those with disc herniations [43] and the other showed superiority at up to 12 months [45] . This resulted in the majority of the evidence relative to use of fluoroscopically guided L-ILESI for radicular pain being classified as observational in nature.
While the quality of evidence is low, the body of evidence does support the conclusion that fluoroscopically guided L-ILESI do provide short-term relief of radicular pain from lumbar disc herniation as well as stenosis. As discussed above this may be an appropriate outcome for acute or subacute radicular pain due to a disc herniation, but may be insufficient for those with chronic neurogenic claudication due to spinal stenosis.
There is a body of literature from one research group in the form of multiple RCTs that claim no differences between lumbar interlaminar epidural injection of lidocaine or corticosteroid for several pathologic conditions including spinal stenosis, disc herniations, and pain of unclear etiology. Surprisingly, these patients tended to have similar strong positive response rates regardless of the underlying etiology or substance injected. These studies, while internally consistent, exhibit dissonance with the remainder of the published literature. They also did not control for the number or timing of the multiple injections the subjects received, and utilized a corticosteroid (betamethasone) that has been shown in other studies to be less effective than other corticosteroid preparations [44, 57, 85] . Due to these considerations it is unclear if these results were due to recurrent methodological flaws, or a lack of effectiveness of betamethasone or even the interlaminar approach.
Several studies have assessed the effectiveness of the parasagittal interlaminar approach compared with either traditional midline L-ILESI or transforaminal injections of steroids [30, 34, 45, 46] . The evidence suggests this technique is significantly more effective than the midline L-ILESI approach in the treatment of radicular pain and possibly of comparable effectiveness to transforaminal injections of steroid for uniradicular pain due to disc herniation.
GRADE Assessment of Risks of Fluoroscopically Guided L-ILESI
When attempting to assess the quality of the evidence on the risks of fluoroscopically guided L-ILESI in accordance with the GRADE system, it is noted that the published evidence consists only of case reports. Accordingly, the body of evidence is of very low quality. That results in very little confidence in the effect estimate and the true effect is likely to be substantially different from the estimate of effect. Readers must be careful not to confuse "evidence of very low quality" with "evidence of little significance" and perhaps go on to dismiss the risks of fluoroscopically guided L-ILESI as too rare to be of concern. The evidence of risks is of very low quality because few cases of serious complications have been published. This may reflect publication bias. There is a tendency for serious complications not to be publicized in papers. Thus, the frequency of complications after fluoroscopically guided L-ILESI is uncertain but when they do occur they can be catastrophic.
Conclusion
There appears to be evidence suggesting a lack of effectiveness of fluoroscopically guided L-ILESI in treating primarily axial pain associated with spinal stenosis or discogenic etiology. Despite the fact that the evidence is of low quality, most studies report significant shortterm improvement in radicular pain after fluoroscopically guided L-ILESI in patients with radicular pain due to lumbar disc herniation and stenosis. 
